List of Tables

Table 1. Inhaled Anti-Infectives Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Inhaled Anti-Infectives Market Restraints

Table 3. Inhaled Anti-Infectives Market Trends

Table 4. Inhaled Anti-Infectives Industry Policy

Table 5. Global Inhaled Anti-Infectives Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Inhaled Anti-Infectives Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Inhaled Anti-Infectives Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Inhaled Anti-Infectives Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Inhaled Anti-Infectives Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Inhaled Anti-Infectives Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Inhaled Anti-Infectives Mergers & Acquisitions, Expansion Plans

Table 12. Global Inhaled Anti-Infectives Manufacturers Product Type

Table 13. Head Office and Inhaled Anti-Infectives Production Site of Key Manufacturer

Table 14. Inhaled Anti-Infectives Capacity of Major Manufacturers and Future Plan

Table 15. China Inhaled Anti-Infectives Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Inhaled Anti-Infectives Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Inhaled Anti-Infectives Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Inhaled Anti-Infectives Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Inhaled Anti-Infectives Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Inhaled Anti-Infectives Production by Region, 2020-2025, (K Units)

Table 21. Global Inhaled Anti-Infectives Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Inhaled Anti-Infectives Upstream (Raw Materials)

Table 23. Global Inhaled Anti-Infectives Typical Customers

Table 24. Inhaled Anti-Infectives Typical Distributors

Table 25. by Type, Global Inhaled Anti-Infectives Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Inhaled Anti-Infectives Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Inhaled Anti-Infectives Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Inhaled Anti-Infectives Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Inhaled Anti-Infectives Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Inhaled Anti-Infectives Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Inhaled Anti-Infectives Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Inhaled Anti-Infectives Sales Quantity Market Share, 2020-2031

Table 35. Astra Zeneca Company Information, Head Office, Market Area, and Industry Position

Table 36. Astra Zeneca Inhaled Anti-Infectives Models, Specifications, and Application

Table 37. Astra Zeneca Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Astra Zeneca Company Profile and Main Business

Table 39. Astra Zeneca Recent Developments

Table 40. Johnson &Johnson Company Information, Head Office, Market Area, and Industry Position

Table 41. Johnson &Johnson Inhaled Anti-Infectives Models, Specifications, and Application

Table 42. Johnson &Johnson Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Johnson &Johnson Company Profile and Main Business

Table 44. Johnson &Johnson Recent Developments

Table 45. Glaxo SmithKline Company Information, Head Office, Market Area, and Industry Position

Table 46. Glaxo SmithKline Inhaled Anti-Infectives Models, Specifications, and Application

Table 47. Glaxo SmithKline Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Glaxo SmithKline Company Profile and Main Business

Table 49. Glaxo SmithKline Recent Developments

Table 50. Novartis AG Company Information, Head Office, Market Area, and Industry Position

Table 51. Novartis AG Inhaled Anti-Infectives Models, Specifications, and Application

Table 52. Novartis AG Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Novartis AG Company Profile and Main Business

Table 54. Novartis AG Recent Developments

Table 55. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 56. Pfizer Inhaled Anti-Infectives Models, Specifications, and Application

Table 57. Pfizer Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Pfizer Company Profile and Main Business

Table 59. Pfizer Recent Developments

Table 60. Wockhardt Company Information, Head Office, Market Area, and Industry Position

Table 61. Wockhardt Inhaled Anti-Infectives Models, Specifications, and Application

Table 62. Wockhardt Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Wockhardt Company Profile and Main Business

Table 64. Wockhardt Recent Developments

Table 65. Roche Company Information, Head Office, Market Area, and Industry Position

Table 66. Roche Inhaled Anti-Infectives Models, Specifications, and Application

Table 67. Roche Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Roche Company Profile and Main Business

Table 69. Roche Recent Developments

Table 70. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 71. Sanofi Inhaled Anti-Infectives Models, Specifications, and Application

Table 72. Sanofi Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Sanofi Company Profile and Main Business

Table 74. Sanofi Recent Developments

Table 75. Merck Company Information, Head Office, Market Area, and Industry Position

Table 76. Merck Inhaled Anti-Infectives Models, Specifications, and Application

Table 77. Merck Inhaled Anti-Infectives Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Merck Company Profile and Main Business

Table 79. Merck Recent Developments

List of Figures

Figure 1. Inhaled Anti-Infectives Picture

Figure 2. Global Inhaled Anti-Infectives Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Inhaled Anti-Infectives Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Inhaled Anti-Infectives Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Inhaled Anti-Infectives Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Inhaled Anti-Infectives Sales Quantity (K Units) & (2020-2031)

Figure 7. China Inhaled Anti-Infectives Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Inhaled Anti-Infectives Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Inhaled Anti-Infectives Market Share of Global, 2020-2031

Figure 10. Global Inhaled Anti-Infectives Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Inhaled Anti-Infectives Key Participants, Market Share, 2024

Figure 12. Global Inhaled Anti-Infectives Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Inhaled Anti-Infectives Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Inhaled Anti-Infectives Production Market Share & Forecast by Region, 2020-2031

Figure 15. Inhaled Anti-Infectives Industry Chain

Figure 16. Inhaled Anti-Infectives Procurement Model

Figure 17. Inhaled Anti-Infectives Sales Model

Figure 18. Inhaled Anti-Infectives Sales Channels, Direct Sales, and Distribution

Figure 19. Aerosol

Figure 20. Dry Powder Formulation

Figure 21. Spray

Figure 22. by Type, Global Inhaled Anti-Infectives Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Inhaled Anti-Infectives Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 25. by Type, Global Inhaled Anti-Infectives Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Inhaled Anti-Infectives Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 27. Hospital Pharmacies

Figure 28. Retail Pharmacies

Figure 29. Online Pharmacies

Figure 30. by Application, Global Inhaled Anti-Infectives Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Inhaled Anti-Infectives Revenue Market Share, 2020-2031

Figure 32. by Application, Global Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 33. by Application, Global Inhaled Anti-Infectives Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Inhaled Anti-Infectives Price, 2020-2031, (US$/Unit)

Figure 35. By Region, Global Inhaled Anti-Infectives Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Inhaled Anti-Infectives Sales Quantity Market Share, 2020-2031

Figure 37. North America Inhaled Anti-Infectives Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Inhaled Anti-Infectives Consumption Value Market Share, 2024

Figure 39. Europe Inhaled Anti-Infectives Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Inhaled Anti-Infectives Consumption Value Market Share, 2024

Figure 41. Asia Pacific Inhaled Anti-Infectives Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Inhaled Anti-Infectives Consumption Value Market Share, 2024

Figure 43. South America Inhaled Anti-Infectives Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Inhaled Anti-Infectives Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Inhaled Anti-Infectives Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 47. by Type, United States Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, Europe Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, China Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, Japan Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, South Korea Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, Southeast Asia Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, India Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Inhaled Anti-Infectives Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, Middle East & Africa Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Inhaled Anti-Infectives Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches